Viking Therapeutics
Drug Discovery · Oncology Therapeutics

Viking Therapeutics revenue, results and funding

Viking Therapeutics holds $0 in public grants on record.

Data updated Nov 22, 2026 · Back to the company report

Results by year

YearLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_BUYBACKSLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASH
2025$1k–$40.8M$345M−$393.3M$165.8M
2024$1k–$29.7M$101.6M−$150.9M$26.7M
2023$1k–$16.8M$63.8M−$100.8M$55.5M
2022$1k$6.8M$8.7M$54.2M−$70.4M$36.6M
2021$2k–$6.1M$45M−$55.7M$26.4M
2020$0–$5.8M$31.9M−$42.7M$29.1M
2019$0–$3.7M$23.6M−$32.7M$8.4M
2018$0–$2.6M$19M−$26.2M$24.8M
2017$0–$1.5M$13.7M−$19.1M$9M
2016$0$229$1.8M$9M−$13.8M$3.1M
2015–$38$2.6M$7M−$12M$769k
2014–$2$6.3k$22.2M−$23.5M$756k
2013–––––$180k
Sources: SEC

How to cite

Viking Therapeutics, Financials. Alion, Nov 22, 2026. https://alion.io/company/vikingtherapeutics/financials

.json · .md · CC BY-SA 4.0